These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2319474)
1. Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes. Roy D; Snodgrass WR J Pharmacol Exp Ther; 1990 Mar; 252(3):895-900. PubMed ID: 2319474 [TBL] [Abstract][Full Text] [Related]
2. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice. Roy D; Snodgrass WR Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010 [TBL] [Abstract][Full Text] [Related]
3. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. Buckpitt AR; Bahnson LS; Franklin RB J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983 [TBL] [Abstract][Full Text] [Related]
4. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins. Juedes MJ; Bulger WH; Kupfer D Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703 [TBL] [Abstract][Full Text] [Related]
5. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans. Masubuchi N; Makino C; Murayama N Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281 [TBL] [Abstract][Full Text] [Related]
6. Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes. Liebler DC; Meredith MJ; Guengerich FP Cancer Res; 1985 Jan; 45(1):186-93. PubMed ID: 3965130 [TBL] [Abstract][Full Text] [Related]
7. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation. Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589 [TBL] [Abstract][Full Text] [Related]
8. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant. Liu L; Wells PG Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459 [TBL] [Abstract][Full Text] [Related]
9. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226 [TBL] [Abstract][Full Text] [Related]
10. Covalent binding of procainamide in vitro and in vivo to hepatic protein in mice. Freeman RW; Uetrecht JP; Woosley RL; Oates JA; Harbison RD Drug Metab Dispos; 1981; 9(3):188-92. PubMed ID: 6166442 [TBL] [Abstract][Full Text] [Related]
11. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine. Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785 [TBL] [Abstract][Full Text] [Related]
12. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Kubow S; Wells PG Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558 [TBL] [Abstract][Full Text] [Related]
13. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. Buckpitt AR; Warren DL J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole. Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258 [TBL] [Abstract][Full Text] [Related]
15. The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen. Streeter AJ; Bjorge SM; Axworthy DB; Nelson SD; Baillie TA Drug Metab Dispos; 1984; 12(5):565-76. PubMed ID: 6149906 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations. Madan A; Parkinson A Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135 [TBL] [Abstract][Full Text] [Related]
17. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177 [TBL] [Abstract][Full Text] [Related]
18. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes. Orton TC; Lowery C J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710 [TBL] [Abstract][Full Text] [Related]
19. Species variation in the bioactivation of tacrine by hepatic microsomes. Madden S; Spaldin V; Hayes RN; Woolf TF; Pool WF; Park BK Xenobiotica; 1995 Jan; 25(1):103-16. PubMed ID: 7604602 [TBL] [Abstract][Full Text] [Related]
20. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol. Buckpitt AR; Boyd MR J Pharmacol Exp Ther; 1980 Oct; 215(1):97-103. PubMed ID: 7452496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]